In Reply
Obstet Gynecol
.
2018 Oct;132(4):1061-1062.
doi: 10.1097/AOG.0000000000002885.
Authors
Mishka Terplan
1
,
Hollis J Laird
2
,
Dennis J Hand
3
,
Tricia E Wright
4
,
Ashish Premkumar
5
,
Caitlin E Martin
6
,
Marjorie C Meyer
7
,
Hendrée E Jones
8
,
Elizabeth E Krans
9
Affiliations
1
Department of Obstetrics and Gynecology and Psychiatry, Virginia Commonwealth University, Richmond, Virginia.
2
Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.
3
Department of Obstetrics & Gynecology, Psychiatry & Human Behavior, Thomas Jefferson University, Philadelphia, Pennsylvania.
4
Department of Obstetrics, Gynecology, and Women's Health, University of Hawaii, Honolulu, Hawaii.
5
Department of Obstetrics and Gynecology, Northwestern University, Chicago, Illinois.
6
Department Obstetrics and Gynecology, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina.
7
Department of Obstetrics, Gynecology & Reproductive Services, University of Vermont, Burlington, Vermont.
8
Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
9
Department of Obstetrics, Gynecology & Reproductive Sciences, Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.
PMID:
30247340
DOI:
10.1097/AOG.0000000000002885
No abstract available
Publication types
Letter
Comment
MeSH terms
Analgesics, Opioid*
Humans
Pregnancy
Substance-Related Disorders*
Substances
Analgesics, Opioid